Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study.
Pradipta R RayAnand PatelChristine Nai-Mei SangPhillip L BanksPhillip F PierceFranklin SunCraig GranowitzSuma GopinathanPublished in: Diabetes care (2024)
These preliminary findings of improvement in DPNP with LX9211 support further investigation in larger trials.